XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Liquidity and Going Concern (Narrative) (Details)
Mar. 31, 2022
USD ($)
shares
Feb. 09, 2022
USD ($)
tranche
$ / shares
shares
Sep. 30, 2023
USD ($)
Jul. 10, 2023
USD ($)
Jan. 10, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Accumulated deficit | $     $ (288,972,000)     $ (239,774,000)  
Cash and cash equivalents | $     $ 23,958,000     $ 14,852,000 $ 25,382,000
Innoviva Strategic Opportunities LLC [Member] | Secured term loan              
Aggregate amount | $       $ 25,000,000.0 $ 30,000,000.0    
Interest rate (as a percent)     27.31% 14.00% 8.00%    
Securities Purchase Agreement [Member] | Innoviva Strategic Opportunities LLC [Member]              
Number of tranches | tranche   2          
Shares Issued, Price Per Share | $ / shares   $ 5.00          
Stock Issued During Period, Shares, New Issues   9,000,000          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   4,500,000          
Exercise price of warrants | $ / shares   $ 5.00          
Securities Purchase Agreement First Tranche [Member] | Innoviva Strategic Opportunities LLC [Member]              
Stock Issued During Period, Shares, New Issues   3,614,792          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   1,807,396          
Proceeds from issuance of common stock and warrants | $   $ 18,100,000          
Securities Purchase Agreement Second Tranche [Member] | Innoviva Strategic Opportunities LLC [Member]              
Stock Issued During Period, Shares, New Issues 5,385,208            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 2,692,604            
Proceeds from issuance of common stock and warrants | $ $ 26,900,000